The Gordon Research Seminar on RNA Nanotechnology is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.
The 2017 RNA Nanotechnology Gordon Research Seminar will focus on RNA nanotechnology and extracellular RNA with separate sessions specifically devoted to Nanoparticle Folding and Structure, RNA nanotechnology, RNA synthetic biology, and the biological roles of extracellular RNA. The first three sessions will emphasize on the current advances in nanoparticle formation and organization that includes both self organizing RNA nanostructure and small, biological RNA elements. These sessions aim to bridge the RNA information boom to applications within therapeutics and industry. The final session will be on the biological roles of extracellular RNA wherein discussion will be focused on the recent developments in our understanding of the multiple roles of extracellular RNA in various physiological and pathological conditions.
This GRS was held in conjunction with the "RNA Nanotechnology" Gordon Research Conference (GRC)
. Refer to the associated GRC program page
for more information.
Final Meeting Program
|2:00 pm - 5:00 pm||Arrival and Check-in|
|3:30 pm - 3:45 pm||Introductory Comments by GRC Site Staff / Welcome by the GRS Conference Chair|
|3:45 pm - 4:30 pm||Keynote Session: The Advancement of the Emerging Field of RNA Nanotechnology|
|Discussion Leader: Ely Porter (Massachusetts Institute of Technology, USA)|
|3:45 pm - 4:20 pm||Peixuan Guo (The Ohio State University, USA)|
"The Advancement of the Emerging Field of RNA Nanotechnology"
|4:20 pm - 4:30 pm||Discussion|
|4:30 pm - 6:00 pm||Poster Session|
|7:30 pm - 9:30 pm||RNA Nanotechnology|
|Discussion Leader: Lorena Parlea (National Cancer Institute, NIH, USA)|
|7:30 pm - 7:55 pm||Jaimie Stewart (University of California, Riverside, USA)|
"Self-Assembly of Multi-Stranded RNA Motifs into Lattices and Tubular Structures with Functional Capabilities"
|7:55 pm - 8:05 pm||Discussion|
|8:05 pm - 8:30 pm||Petr Sulc (The Rockefeller University, USA)|
"Coarse Grained Modeling of RNA for Nanotechnology"
|8:30 pm - 8:40 pm||Discussion|
|8:40 pm - 9:05 pm||Mario Vieweger (The Ohio State University, USA)|
"RNA Dendrimers for Therapeutics Applications"
|9:05 pm - 9:15 pm||Discussion|
|9:15 pm - 9:30 pm||General Discussion|
|7:30 am - 8:30 am||Breakfast|
|9:00 am - 11:00 am||RNA Nanomedicine|
|Discussion Leader: Jean Bosco Tagne (Boston University School of Medicine, USA)|
|9:00 am - 9:25 am||Jean Bosco Tagne (Boston University School of Medicine, USA)|
"Encapsulated miRNAs as Disease Therapeutics"
|9:25 am - 9:30 am||Discussion|
|9:30 am - 9:55 am||Irfan Khan (The RNA Institute, University at Albany, SUNY, USA)|
"In Vitro Controlled Activation of Inactive siRNA"
|9:55 am - 10:00 am||Discussion|
|10:00 am - 10:25 am||Paul Zakrevsky (National Cancer Institute, NIH, USA)|
"Conditional Gene Silencing Mediated by a Dynamic RNA Switch"
|10:25 am - 10:30 am||Discussion|
|10:30 am - 10:55 am||Victoria Goldsworthy (Ball State University, USA)|
"RNA Nanotechnology and Fabrication of De Novo RNA Nanodevices"
|10:55 am - 11:00 am||Discussion|
|11:00 am - 12:30 pm||Poster Session|
|Coffee will be served in the poster area from 11:00 am - 11:30 am|
|1:30 pm - 2:30 pm||Extracellular Vesicles, RNA and Its Applications|
|Discussion Leader: Jan Lotvall (University of Gothenburg, Sweden)|
|1:30 pm - 1:55 pm||Zhefeng Li (Ohio State University, USA)|
"Large-Scale Isolation of High Purity Ginger Derived Exosome-Like Nanovesicle as Carrier for Gene Therapy"
|1:55 pm - 2:00 pm||Discussion|
|2:00 pm - 2:25 pm||Caroline Horizny (Colleges of Nanoscale Science and Engineering, SUNY Polytechnic Institute, USA)|
"Modified Structurally Interacting RNAs for the Detection and Identification of Intracellular and Exosomal microRNAs"
|2:25 pm - 2:30 pm||Discussion|
|2:30 pm - 3:00 pm||Evaluation Period|
|Fill in GRS Evaluation Forms|
|3:00 pm||Seminar Concludes|
Funding for this conference was made possible NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.